Rafeh Naqash: Clinical and tumor immunophenotypic characteristics in older adults with NSCLC
Rafeh Naqash, Associate Professor and Director of Clinical Research at UT Southwestern Medical Center, shared a recent article on X by Adriana P.C. Barrichello et al., titled “Tumor immunophenotypic correlates in patients aged 80 years or older with non-small cell lung cancer and outcomes to first-line pembrolizumab in PD-L1 high (≥50%) patients” published on Clinical Lung Cancer.
Authors: Adriana P.C. Barrichello, Arielle Elkrief, Biagio Ricciuti, Teja Ganta, Thomas U. Marron, Xinan Wang, William Lotter, James Lindsay, Valentina Santo, Alessio Cortellini, Bijaya Sharma, Kristen Felt, Kathleen Pfaff, Giuseppe Lamberti, Federica Peccia, Alessandro Di Federico, Maisam Makarem, Malini M. Gandhi, Tom Nguyen, Danielle Haradon, Victor R. Vaza, Bruce E. Johnson, Neha Debnath, Yinghong Wang, Andrew G. Kuang, Anwaar Saeed, Maluki Radford, Christine M. Lovly, Caroline A. Nebhan, David J. Pinato, Scott J. Rodig, Adam J. Schoenfeld, Mark M. Awada, Joao V. Alessia, Abdul Rafeh Naqash.
“Labour of love for 2 years now published in Clinical Lung Cancer. Largest study on clinical and tumor immunophenotypic characteristics in older adults with NSCLC and PDL1>50. Phenomenal work by Biagio Ricciut, João Alessi, Valentina Santo, Adriana Barrichello to take this to finish line!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023